Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib With Tacrolimus/Sirolimus for GVHD Prophylaxis in Stem Cell Transplantation
NCT04339101Phase 2Completed
- Sponsor
- City of Hope
- Start
- Nov 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of itacitinib in graft-versus-host disease (GVHD), sponsored by City of Hope. Started Nov 2020; status: completed.
02
Drugs
itacitinib
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT04339101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04339101.